Serum IgG to heat shock proteins and Porphyromonas gingivalis antigens in diabetic patients with periodontitis.

作者: Tom J. Sims , Ake Lernmark , Lloyd A. Mancl , Robert E. Schifferle , Roy C. Page

DOI: 10.1034/J.1600-051X.2002.290612.X

关键词:

摘要: Background:Past studies have reported a correlation between the presence and severity of periodontitis serum antibody titers to species-specific antigens Porphyromonas gingivalis or cross-reactive antigens, such as lipopolysaccharide (LPS) heat shock proteins (HSP), shared P. other bacteria. Our recent study periodontal treatment outcome in insulin-dependent (type 1) diabetes mellitus patients with severe (IDDMI/periodontitis) resulted two key findings: 1. glutamic acid decarboxylase autoantibody (GAD65 Ab) levels were significantly associated pocket depth change (PDC) 2. IgG cells positively GAD65 Ab level seropositive +) patients. We therefore hypothesized that profiles titers, gingivalis-specific may be useful assessing risk for refractory Aim:To determine whether PDC resulting from non-surgical can predicted using baseline gingivalisspecific human HSP, GAD65. Methods:PDC was assessed months after 7 + 11 AbIDDM/periodontitis Pretreatment GAD65, recombinant (HSP90, HSP70, HSP60), various measured radioligand precipitation enzyme-linked immunosorbent (ELISA) assays compared same measurements 154 recent-onset IDDM 46 non-diabetic controls. Results:Median (ELISA units) HSP90 HSP70 higher than controls (p°= 0.002) Ab- (p = 0.034) IDDM/periodontitis patients, respectively. Multivariate regression analysis indicated significant partial log-transformed (r − 0.62, p 0.008), 0.009), 0.60, 0.01) LPS 0.5 1, 0.04). Furthermore, hierarchical clustering HSP90, sorted into distinct clusters different median (1.45 min, n 10 vs. 0.65 8; 0.016, Mann–Whitney). Conclusion:Pretreatment predicting which will poor response therapy. (Less)

参考文章(44)
Jan Lindhe, Elisabeth Westfelt, Sture Nyman, Sigmund S. Socransky, Lars Heijl, Gunilla Bratthall, Healing following surgical/non-surgical treatment of periodontal disease. A clinical study. Journal of Clinical Periodontology. ,vol. 9, pp. 115- 128 ,(1982) , 10.1111/J.1600-051X.1982.TB01227.X
Ann L. Griffen, Mitzi R. Becker, Sharon R. Lyons, Melvin L. Moeschberger, Eugene J. Leys, Prevalence of Porphyromonas gingivalis and Periodontal Health Status Journal of Clinical Microbiology. ,vol. 36, pp. 3239- 3242 ,(1998) , 10.1128/JCM.36.11.3239-3242.1998
Carl J. Gustke, Treatment of periodontitis in the diabetic patient. A critical review. Journal of Clinical Periodontology. ,vol. 26, pp. 133- 137 ,(1999) , 10.1034/J.1600-051X.1999.260301.X
George W Taylor, Brian A Burt, Mark P Becker, Robert J Genco, Marc Shlossman, William C Knowler, David J Pettitt, None, Severe Periodontitis and Risk for Poor Glycemic Control in Patients with Non-Insulin-Dependent Diabetes Mellitus Journal of Periodontology. ,vol. 67, pp. 1085- 1093 ,(1996) , 10.1902/JOP.1996.67.10S.1085
Sara G. Grossi, Joseph J. Zambon, Alex W. Ho, Gary Koch, Robert G. Dunford, Eli E. Machtei, Ola M. Norderyd, Robert J. Genco, Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. Journal of Periodontology. ,vol. 65, pp. 260- 267 ,(1994) , 10.1902/JOP.1994.65.3.260
Dennis E. Lopatin, Eduardo Jaramillo, Chris A. Edwards, Neal Poperin, Allison Combs, Charles E. Shelburne, Cellular localization of a Hsp90 homologue in Porphyromonas gingivalis Fems Microbiology Letters. ,vol. 181, pp. 9- 16 ,(1999) , 10.1111/J.1574-6968.1999.TB08820.X